Blue Chip Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.1M | Buy |
249,913
+5,084
| +2% | +$587K | 2.16% | 18 |
|
|
2025
Q4 | $25.8M | Buy |
244,829
+16,411
| +7% | +$1.54M | 1.87% | 22 |
|
|
2025
Q3 | $19.2M | Buy |
228,418
+11,821
| +5% | +$974K | 1.43% | 28 |
|
|
2025
Q2 | $17.1M | Buy |
216,597
+26,140
| +14% | +$2.08M | 1.4% | 28 |
|
|
2025
Q1 | $17.1M | Buy |
190,457
+41,970
| +28% | +$3.92M | 1.47% | 24 |
|
|
2024
Q4 | $14.8M | Sell |
148,487
-19,929
| -12% | -$2.05M | 1.27% | 29 |
|
|
2024
Q3 | $19.1M | Buy |
168,416
+5,777
| +4% | +$686K | 1.66% | 25 |
|
|
2024
Q2 | $20.1M | Buy |
162,639
+6,961
| +4% | +$897K | 1.86% | 23 |
|
|
2024
Q1 | $20.5M | Buy |
155,678
+13,303
| +9% | +$1.64M | 1.99% | 21 |
|
|
2023
Q4 | $15.5M | Buy |
142,375
+15,757
| +12% | +$1.64M | 1.62% | 28 |
|
|
2023
Q3 | $13M | Buy |
126,618
+103,142
| +439% | +$11.1M | 1.55% | 28 |
|
|
2023
Q2 | $2.71M | Sell |
23,476
-299
| -1% | -$33.9K | 0.31% | 49 |
|
|
2023
Q1 | $2.53M | Sell |
23,775
-1,282
| -5% | -$138K | 0.3% | 52 |
|
|
2022
Q4 | $2.78M | Sell |
25,057
-837
| -3% | -$85.6K | 0.35% | 53 |
|
|
2022
Q3 | $2.23M | Buy |
25,894
+188
| +0.7% | +$16.8K | 0.31% | 51 |
|
|
2022
Q2 | $2.34M | Buy |
25,706
+359
| +1% | +$31.8K | 0.3% | 53 |
|
|
2022
Q1 | $2.08M | Sell |
25,347
-1,373
| -5% | -$108K | 0.26% | 57 |
|
|
2021
Q4 | $2.05M | Buy |
26,720
+227
| +0.9% | +$18.1K | 0.26% | 55 |
|
|
2021
Q3 | $1.99M | Sell |
26,493
-1,010
| -4% | -$76.8K | 0.28% | 48 |
|
|
2021
Q2 | $2.14M | Sell |
27,503
-2,538
| -8% | -$189K | 0.31% | 49 |
|
|
2021
Q1 | $2.21M | Sell |
30,041
-1,719
| -5% | -$127K | 0.34% | 46 |
|
|
2020
Q4 | $2.48M | Sell |
31,760
-2,910
| -8% | -$223K | 0.39% | 44 |
|
|
2020
Q3 | $2.74M | Sell |
34,670
-467
| -1% | -$36.6K | 0.49% | 37 |
|
|
2020
Q2 | $2.59M | Sell |
35,137
-1,339
| -4% | -$101K | 0.51% | 37 |
|
|
2020
Q1 | $2.68M | Sell |
36,476
-4,566
| -11% | -$359K | 0.67% | 35 |
|
|
2019
Q4 | $3.56M | Buy |
41,042
+1,203
| +3% | +$98.8K | 0.68% | 41 |
|
|
2019
Q3 | $3.2M | Buy |
39,839
+2,480
| +7% | +$199K | 0.68% | 41 |
|
|
2019
Q2 | $2.99M | Buy |
37,359
+656
| +2% | +$50.2K | 0.67% | 43 |
|
|
2019
Q1 | $2.91M | Buy |
36,703
+247
| +0.7% | +$18.5K | 0.69% | 44 |
|
|
2018
Q4 | $2.66M | Sell |
36,456
-1,234
| -3% | -$87.1K | 0.67% | 43 |
|
|
2018
Q3 | $2.55M | Sell |
37,690
-1,217
| -3% | -$77.5K | 0.62% | 44 |
|
|
2018
Q2 | $2.25M | Sell |
38,907
-3,217
| -8% | -$181K | 0.6% | 47 |
|
|
2018
Q1 | $2.19M | Sell |
42,124
-4,450
| -10% | -$240K | 0.61% | 50 |
|
|
2017
Q4 | $2.5M | Sell |
46,574
-2,567
| -5% | -$142K | 0.74% | 45 |
|
|
2017
Q3 | $3M | Sell |
49,141
-730
| -1% | -$44.3K | 0.97% | 37 |
|
|
2017
Q2 | $3.05M | Buy |
49,871
+456
| +0.9% | +$27.8K | 1.06% | 34 |
|
|
2017
Q1 | $3M | Sell |
49,415
-3,334
| -6% | -$202K | 1.13% | 29 |
|
|
2016
Q4 | $2.96M | Sell |
52,749
-2,887
| -5% | -$169K | 1.16% | 30 |
|
|
2016
Q3 | $3.31M | Sell |
55,636
-1,211
| -2% | -$70.8K | 1.46% | 26 |
|
|
2016
Q2 | $3.13M | Sell |
56,847
-1,315
| -2% | -$70K | 1.41% | 27 |
|
|
2016
Q1 | $2.94M | Buy |
58,162
+1,001
| +2% | +$49K | 1.43% | 26 |
|
|
2015
Q4 | $2.88M | Buy |
57,161
+525
| +0.9% | +$26.5K | 1.5% | 24 |
|
|
2015
Q3 | $2.67M | Buy |
56,636
+3,742
| +7% | +$199K | 1.7% | 23 |
|
|
2015
Q2 | $2.87M | Buy |
52,894
+3,050
| +6% | +$171K | 1.84% | 23 |
|
|
2015
Q1 | $2.73M | Sell |
49,844
-1,815
| -4% | -$103K | 1.85% | 22 |
|
|
2014
Q4 | $2.8M | Buy |
+51,659
| New | +$2.88M | 1.95% | 19 |
|
Other funds holding MRK
VCM
VPM
Blue Chip Partners's MRK Position: Q1 2026 in Review
Blue Chip Partners increased its Merck (MRK) stake by 2.1% in Q1 2026, buying an estimated $587K and bringing the position to 249,913 shares worth $30.1M. The position accounts for 2.16% of the portfolio, ranked #18.
Blue Chip Partners first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Blue Chip Partners held 249,913 shares of Merck worth $30.1M as of Q1 2026.
- Blue Chip Partners bought 5,084 Merck shares in Q1 2026, an estimated $587K.
- Merck made up 2.16% of Blue Chip Partners's portfolio in Q1 2026, its #18 holding.
- Blue Chip Partners first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Blue Chip Partners's 13F filing for Q1 2026, filed 15 May 2026.